A CASE STUDY ON SHORT TERM ESCALATING DOSE OF LARGE AMOUNT SNEHA DOES NOT INCREASE BLOOD CHOLESTEROL LEVEL

Background: In Ayurveda, Sneha Pana (internal oleation withmedicated ghee) is often used as part of Panchakarma therapy.Madhumeha, known as Type 2 Diabetes Mellitus (T2DM) in modernmedicine, is a metabolic disorder characterized by chronichyperglycemia due to insulin resistance. Over time, it is oftenassociated with various cardiovascular risk factors, includinghyperlipidemia. The altered lipid metabolism in T2DM patientssignificantly increases the risk of atherosclerosis and cardiovasculardiseases, making it crucial to understand the interplay betweenhyperlipidemia and Madhumeha. Concerns exist regarding the impactof high ghee doses on cholesterol levels, particularly in patients withmetabolic disorders like Madhumeha (Type 2 Diabetes Mellitus). Thepresent study aims to clear this myth that escalating doses of Snehacauses hyperlipidaemia in the patients of diabetes mellitus. CasePresentation: A 55-year-old male with well-controlled Type 2diabetes underwent a 6-day Sneha Pana regimen using escalatingdoses of Indukanta Ghrita. The patient underwent a treatment protocolthat included Snehapana (medicated ghee administration) followed by Virechana (purgationtherapy) as part of an Ayurvedic intervention. Investigations revealed changes in variousbiochemical parameters, including fasting blood sugar (FBS), lipid profile, and liver functiontests. This case highlights the importance of monitoring metabolic changes during traditional Ayurvedic therapies in patients with diabetes. Despite consuming a cumulative mL of ghee, post-therapy lipid profiles showed no significant changes in cholesterol, LDL, or triglycerides. Conclusion: This case suggests that large, short-term doses of Sneha, when used as part of Ayurvedic therapy for patients with Type 2 diabetes, do not lead to significant increases in blood cholesterol levels.